This page is an unofficial mirror and is not legal advice. Verify the document against the official source before relying on it.
SB465: classifying xylazine as a schedule III controlled drug.
Bill details
No mirrored bill text is available for this bill yet. Use the official source links below for the full current record.
Version history, amendments, and roll-call votes were not present in the imported local bill data.
Official links
Extraction diagnostics
Related law links
RSA references from bill data
-
318-B
· amend
· effective 2027-01-01
s a schedule III controlled drug. Be it Enacted by the Senate and House of Representatives in General Court convened: 1 New Section; Controlled Drug Act; Xylazine. Amend RSA 318-B by inserting after section 1-c the following new section: 318-B:1-d Xylazine. I. Notwithstanding the provisions of RSA 318-B:1-a, relative to scheduling by rulemaking of the commissioner of the department of healt
-
318-B:1-A
· amend
· effective 2027-01-01
w Section; Controlled Drug Act; Xylazine. Amend RSA 318-B by inserting after section 1-c the following new section: 318-B:1-d Xylazine. I. Notwithstanding the provisions of RSA 318-B:1-a, relative to scheduling by rulemaking of the commissioner of the department of health and human services, xylazine shall be scheduled as a schedule III controlled drug. II. Notwithstanding paragraph I, nothing in this
-
332-B:1
· reference
· effective 2027-01-01
s, xylazine shall be scheduled as a schedule III controlled drug. II. Notwithstanding paragraph I, nothing in this section shall prevent any licensed veterinarian, as defined in RSA 332-B:1, from doing any of the following: (a) Dispensing or prescribing for, or administering to, a nonhuman species of a drug containing xylazine that has been approved by the Secretary of Health and Human Services under s